BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2011
View Archived Issues
Novel free fatty acid FFA1 receptor agonists for diabetes claimed by Lilly
Read More
Preclinical safety data on FCFD-4514-S enable advancement to clinic for geographic atrophy
Read More
Clinical trial tests effect of food, H2R blockade and vitamin C on GSK-1322322 pharmacokinetics
Read More
PEM antibiotic POL-7080 well tolerated in phase I study
Read More
KAG-308 has beneficial effects in models of chronic colitis
Read More
Preclinical data disclosed on RDX-5791 for constipation
Read More
New anticancer agents prepared by Chinese scientists
Read More
OPKO Health receives grant to support development of therapeutics for Dravet syndrome
Read More
Merck & Co. patents novel acyl-CoA desaturase inhibitors
Read More
Biodel's ultrarapidly acting insulin formulations enter pump trial in type 1 diabetes
Read More
FDA clears Meridian Bioscience's Premier C. difficile GDH immunoassay
Read More
Novel antibacterial agents presented
Read More
Tibotec designs novel HIV integrase inhibitors
Read More
Encore Therapeutics finalizes novel nanoemulsion progesterone formulation ETI-411
Read More
New calcitonin CGRP receptor antagonists disclosed
Read More
Duquesne University presents new tamoxifen-melatonin hybrid ligand
Read More
Nymox to begin recruitment in new clinical trial of NX-1207
Read More
Talon Therapeutics to begin recruitment in phase III Marqibo trial
Read More
Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation
Read More
Summit nominates SMT-19969 as preclinical development candidate against C. difficile infection
Read More
Verona Pharma begins new phase II trial of RPL-554 in asthma
Read More
EMA acknowledges that Clinuvel's proposed dossier for afamelanotide meets all filing requirements
Read More
Meda completes acquisition of atopic dermatitis treatment Elidel
Read More
Hervix has long-term benefit on recurrence of bladder cancer
Read More
CrystalGenomics completes phase I trial of CG-400549, an antibiotic against resistant bacteria
Read More